BridgeBio Pharma Inc (BBIO)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$38.55
Buy
$38.70
$0.17 (+0.44%)
Prices updated at 02 May 2025, 23:07 EDT
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 9m | 222m | |
| 7m | 218m | |
| -599m | -577m | |
| -6,443.56 | -260.19 | |
| -643m | -536m | |
| -565m | -437m | |
| Sales, General and administrative | 151m | 289m |
| Interest expenses | 81m | 99m |
| Provision for income taxes | - | 1m |
| Operating expenses | 606m | 795m |
| Income before taxes | -653m | -542m |
| Net income available to common shareholders | -643m | -536m |
| -3.95 | -2.88 | |
| Net interest income | -63m | -82m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -3.95 | -2.88 |
| Free cash flow per share | -3.1807 | -2.5027 |
| Book value/share | -6.897 | -6.4718 |
| Debt equity ratio | - | - |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 478m | 721m |
| Current liabilities | 144m | 154m |
| Total capital | 372m | 253m |
| Total debt | 1,740m | 1,731m |
| Total equity | -1,354m | -1,468m |
| Total non current liabilities | - | - |
| Loans | 1,727m | 1,721m |
| Total assets | 546m | 919m |
| Total liabilities | - | - |
| Cash and cash equivalents | 376m | 681m |
| Common stock | 175m | 190m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 417m | 395m |
| Cash dividends paid | - | - |
| -529m | -530m | |
| Investments (gains) losses | 54m | 61m |
| 395m | 683m | |
| Net income | - | - |
| -528m | -521m | |
| -1m | -9m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
